tiprankstipranks
Trending News
More News >
Option Care Health (OPCH)
NASDAQ:OPCH
US Market

Option Care Health (OPCH) Ratios

Compare
444 Followers

Option Care Health Ratios

OPCH's free cash flow for Q4 2024 was $0.20. For the 2024 fiscal year, OPCH's free cash flow was decreased by $ and operating cash flow was $0.07. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
1.70 1.77 1.76 1.55 1.51
Quick Ratio
1.20 1.33 1.36 1.15 1.15
Cash Ratio
0.53 0.56 0.52 0.26 0.23
Solvency Ratio
0.14 0.18 0.14 0.14 0.05
Operating Cash Flow Ratio
0.41 0.60 0.47 0.45 0.29
Short-Term Operating Cash Flow Coverage
11.32 61.88 10.54 8.31 4.53
Net Current Asset Value
$ -694.88M$ -701.11M$ -732.49M$ -904.78M$ -974.70M
Leverage Ratios
Debt-to-Assets Ratio
0.03 0.36 0.35 0.38 0.42
Debt-to-Equity Ratio
0.08 0.82 0.78 0.90 1.10
Debt-to-Capital Ratio
0.07 0.45 0.44 0.47 0.52
Long-Term Debt-to-Capital Ratio
0.06 0.43 0.43 0.47 0.52
Financial Leverage Ratio
2.44 2.26 2.25 2.37 2.61
Debt Service Coverage Ratio
4.18 6.84 3.67 3.03 1.32
Interest Coverage Ratio
6.56 6.14 4.46 2.85 1.03
Debt to Market Cap
0.03 0.18 0.20 0.21 0.40
Interest Debt Per Share
0.95 6.80 6.28 6.27 6.76
Net Debt to EBITDA
-0.76 1.70 2.28 3.67 5.56
Profitability Margins
Gross Profit Margin
20.27%22.81%21.98%22.67%22.50%
EBIT Margin
6.65%9.53%6.61%5.55%2.83%
EBITDA Margin
7.93%11.23%8.77%7.44%6.02%
Operating Profit Margin
6.44%7.31%6.09%5.55%3.65%
Pretax Profit Margin
5.67%8.34%5.22%3.39%-0.17%
Net Profit Margin
4.24%6.21%3.82%4.07%-0.27%
Continuous Operations Profit Margin
4.24%6.21%3.82%4.07%-0.27%
Net Income Per EBT
74.69%74.45%73.17%120.09%154.03%
EBT Per EBIT
88.12%114.03%85.65%61.04%-4.73%
Return on Assets (ROA)
6.19%8.30%4.84%5.01%-0.31%
Return on Equity (ROE)
15.08%18.79%10.86%11.90%-0.80%
Return on Capital Employed (ROCE)
12.18%12.11%9.43%8.19%5.00%
Return on Invested Capital (ROIC)
8.93%8.93%6.78%9.65%7.55%
Return on Tangible Assets
11.36%19.91%12.39%14.77%-0.93%
Earnings Yield
5.32%4.43%2.76%2.74%-0.29%
Efficiency Ratios
Receivables Turnover
12.20 11.39 10.45 10.17 9.24
Payables Turnover
6.52 7.79 8.13 9.52 8.31
Inventory Turnover
10.27 12.12 13.72 14.52 14.82
Fixed Asset Turnover
23.37 21.01 36.42 30.83 25.03
Asset Turnover
1.46 1.34 1.27 1.23 1.15
Working Capital Turnover Ratio
9.82 9.51 11.61 14.52 13.43
Cash Conversion Cycle
9.53 15.28 16.61 22.70 20.21
Days of Sales Outstanding
29.92 32.04 34.93 35.90 39.52
Days of Inventory Outstanding
35.55 30.11 26.60 25.13 24.63
Days of Payables Outstanding
55.94 46.88 44.92 38.33 43.94
Operating Cycle
65.47 62.15 61.53 61.04 64.15
Cash Flow Ratios
Operating Cash Flow Per Share
1.88 2.07 1.48 1.16 0.70
Free Cash Flow Per Share
1.88 1.84 1.28 1.02 0.56
CapEx Per Share
0.00 0.23 0.20 0.14 0.15
Free Cash Flow to Operating Cash Flow
1.00 0.89 0.87 0.88 0.79
Dividend Paid and CapEx Coverage Ratio
0.00 8.87 7.57 8.14 4.74
Capital Expenditure Coverage Ratio
0.00 8.87 7.57 8.14 4.74
Operating Cash Flow Coverage Ratio
2.85 0.32 0.25 0.20 0.11
Operating Cash Flow to Sales Ratio
0.06 0.09 0.07 0.06 0.04
Free Cash Flow Yield
8.12%5.46%4.26%3.58%3.55%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
18.79 22.58 36.20 36.56 -350.47
Price-to-Sales (P/S) Ratio
0.80 1.40 1.38 1.49 0.93
Price-to-Book (P/B) Ratio
2.83 4.24 3.93 4.35 2.79
Price-to-Free Cash Flow (P/FCF) Ratio
12.31 18.30 23.47 27.96 28.16
Price-to-Operating Cash Flow Ratio
12.31 16.24 20.37 24.52 22.22
Price-to-Earnings Growth (PEG) Ratio
-1.08 0.28 5.65 -0.02 3.86
Price-to-Fair Value
2.83 4.24 3.93 4.35 2.79
Enterprise Value Multiple
9.29 14.18 18.04 23.66 21.06
EV to EBITDA
9.29 14.18 18.04 23.66 21.06
EV to Sales
0.74 1.59 1.58 1.76 1.27
EV to Free Cash Flow
11.38 20.80 26.87 33.10 38.26
EV to Operating Cash Flow
11.38 18.45 23.32 29.03 30.19
Tangible Book Value Per Share
-0.89 -2.54 -2.82 -3.71 -4.22
Shareholders’ Equity Per Share
8.18 7.94 7.65 6.54 5.61
Tax and Other Ratios
Effective Tax Rate
0.25 0.26 0.27 -0.20 -0.54
Revenue Per Share
29.13 24.04 21.78 19.12 16.76
Net Income Per Share
1.23 1.49 0.83 0.78 -0.04
Tax Burden
0.75 0.74 0.73 1.20 1.54
Interest Burden
0.85 0.88 0.79 0.61 -0.06
Research & Development to Revenue
0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
0.00 0.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
<0.01 <0.01 <0.01 <0.01 <0.01
Income Quality
1.53 1.39 1.78 1.49 -15.77
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis